Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Amitriptyline, fluoxetine and tramadol alone (control group)[3] Amitriptyline,
Fluoxetine,
Tramadol		[3] D00326 (Name: Fluoxetine),
D07448 ,
D08623 		[3] OPRM1,
SLC6A2,
SLC6A4 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 78
2Fluoxetin[1] Fluoxetine[1] D00326 (Name: Fluoxetine)[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[3] 13, 179, 206
3Fluoxetin Hexal[1] Fluoxetine[1] D00326 (Name: Fluoxetine)[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13
4FLUOXETINE[1] Fluoxetine[1] D00326 (Name: Fluoxetine)[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[4] 13, 17, 78, 86
5FLUOXETINE HYDROCHLORIDE[1] Fluoxetine[1] D00326 (Name: Fluoxetine)[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13
6Methylphenidate, fluoxetin, risperidone[3] Fluoxetine,
Methylphenidate,
Risperidone		[3] D00326 (Name: Fluoxetine),
D00426 ,
D04999 		[5] DRD2,
HTR2A,
SLC6A2,
SLC6A3,
SLC6A4 💬		[14] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬[2] 179, 206
7Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)[4] Amitriptyline,
Fluoxetine,
Somatotropin,
Tramadol		[3] D00326 (Name: Fluoxetine),
D07448 ,
D08623 		[3] OPRM1,
SLC6A2,
SLC6A4 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 78